Bionano Genomics, Inc. Common Stock vs. Waters Corp
Bionano Genomics, Inc. Common Stock (BNGO) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| BNGO | WAT | |
|---|---|---|
| Market Cap | $14.13 million | $40.98 billion |
| Revenue (TTM) | $30.18 million | — |
| Net Income (TTM) | $-32,162,000 | — |
WAT leads on 1 of 1 size & scale factors.
Valuation
| BNGO | WAT | |
|---|---|---|
| Price / Book | 0.45 | 2.70 |
| Price / Sales | 0.47 | — |
BNGO leads on 1 of 1 valuation factors.
Profitability
| BNGO | WAT | |
|---|---|---|
| Net Margin | -106.58% | — |
| Return on Equity | -101.76% | — |
BNGO and WAT split the profitability factors evenly.
Risk & Sentiment
| BNGO | WAT | |
|---|---|---|
| Short Interest | 0.15% | 3.23% |
BNGO leads on 1 of 1 risk & sentiment factors.
Dig deeper: BNGO overview, BNGO financials, WAT overview, WAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.